Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2025
Oct. 31, 2024
Current assets:    
Cash and cash equivalents $ 44,394 $ 43,041
Receivables, net of allowance for doubtful accounts of $905 and $916, respectively 53,132 56,441
Inventory, net 7,419 5,922
Prepaid expenses and other current assets 8,408 6,956
Total current assets 113,353 112,360
Property, plant and equipment, net 412,516 415,726
Intangible assets, net 93,933 105,612
Goodwill 223,581 222,996
Right-of-use operating lease assets 22,943 26,179
Other non-current assets 11,195 12,578
Deferred financing costs 2,021 2,539
Total assets 879,542 897,990
Current liabilities:    
Revolving loan 0 20
Operating lease obligations, current portion 4,851 4,817
Accounts payable 6,267 7,668
Accrued payroll and payroll expenses 11,973 14,303
Accrued expenses and other current liabilities 28,730 28,673
Income taxes payable 463 850
Total current liabilities 52,284 56,331
Long term debt, net of discount for deferred financing costs 417,891 373,260
Operating lease obligations, non-current 18,659 21,716
Deferred income taxes 89,431 86,647
Other non-current liabilities 11,488 13,321
Total liabilities 589,753 551,275
Commitments and contingencies (Note 18)
Zero-dividend convertible perpetual preferred stock, $0.0001 par value, 2,450,980 shares issued and outstanding as of October 31, 2025 and October 31, 2024 25,000 25,000
Stockholders' equity    
Common stock, $0.0001 par value, 500,000,000 shares authorized, 51,272,503 and 53,273,644 issued and outstanding as of October 31, 2025 and October 31, 2024, respectively 6 6
Additional paid-in capital 389,880 386,313
Treasury stock (41,687) (25,881)
Accumulated other comprehensive income (loss) 1,589 (483)
Accumulated deficit (84,999) (38,240)
Total stockholders' equity 264,789 321,715
Total liabilities and stockholders' equity $ 879,542 $ 897,990